1 iHuman Institute, ShanghaiTech University, Shanghai, China.
2 School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
3 Center for Excellence in Molecular Cell Science, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.
4 University of Chinese Academy of Sciences, Beijing, China.
5 Section of Receptor Biology & Signaling, Department of Physiology & Pharmacology, Karolinska Institutet, Stockholm, Sweden.
6 Institute for Research in Immunology and Cancer, Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, QC, Canada.
7 Orion Pharma R&D, Espoo, Finland.
8 Departments of Biological Sciences and Chemistry, Bridge Institute, University of Southern California, Los Angeles, CA, USA.
9 Section of Receptor Biology & Signaling, Department of Physiology & Pharmacology, Karolinska Institutet, Stockholm, Sweden. gunnar.schulte@ki.se.
10 iHuman Institute, ShanghaiTech University, Shanghai, China. xufei@shanghaitech.edu.cn.
11 School of Life Science and Technology, ShanghaiTech University, Shanghai, China. xufei@shanghaitech.edu.cn.
12 Center for Excellence in Molecular Cell Science, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China. xufei@shanghaitech.edu.cn.
13 University of Chinese Academy of Sciences, Beijing, China. xufei@shanghaitech.edu.cn.